MX9705209A - Preparacion estabilizada de factor viii recombinante, libre de albumina, que tiene un bajo contenido de azucares. - Google Patents
Preparacion estabilizada de factor viii recombinante, libre de albumina, que tiene un bajo contenido de azucares.Info
- Publication number
- MX9705209A MX9705209A MX9705209A MX9705209A MX9705209A MX 9705209 A MX9705209 A MX 9705209A MX 9705209 A MX9705209 A MX 9705209A MX 9705209 A MX9705209 A MX 9705209A MX 9705209 A MX9705209 A MX 9705209A
- Authority
- MX
- Mexico
- Prior art keywords
- factor viii
- recombinant factor
- sugar content
- free recombinant
- low sugar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Una formulacion estable, libre de albumina, del factor VIII recombinante (rFVIII) en forma liofilizada que contiene tanto componentes cristalinos como así también amorfos, y que comprende, después de ser reconstituida con agua, aproximadamente 65 a 400 mM de glicina, hasta 50 mM de histidina, 15 a 60 mM de sucrosa, hasta 50 mM de NaCl, hasta 5 mM de CaCl2, y de 50 a 1500 IU/ml de rFVIII. Una formulacion muy preferida comprende, después de haber sido reconstituida con agua, alrededor de 290 mM de glicina, 20 mM de histidina, 30 mM de sucrosa, 30 mM de NaCl, 2.5 mM de CaCl2, y de 50 a 1500 IU/ml de rFVIII. El contenido de agua residual de la preparacion es de aproximadamente 1 a 3% en peso, de preferencia del 1% en peso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/678,492 US5763401A (en) | 1996-07-12 | 1996-07-12 | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
US08678492 | 1996-07-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9705209A true MX9705209A (es) | 1998-05-31 |
MXPA97005209A MXPA97005209A (es) | 1998-10-23 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY125544A (en) | Stabilized albumin-free recombinant factor viii preparation having a low sugar content | |
RU97111733A (ru) | Устойчивая, свободная от альбумина лиофилизованная композиция рекомбинантного фактора viii | |
PL313084A1 (en) | Pharmaceutic formulation of nerve growth factor | |
CA2413334A1 (en) | Stabilized interleukin 2 | |
WO1995013297A3 (en) | Improved immunogenic compositions against human gastrin 17 | |
ES8704350A1 (es) | Procedimiento para la preparacion de un conjugado bacteriano | |
AU4478093A (en) | PEG-interferon conjugates | |
AU5649586A (en) | Partially purified bone-inducing factor | |
GR3035067T3 (en) | Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins. | |
HU9401831D0 (en) | Stabilized pharmaceutical formulations comprising growth hormone and asparagine | |
WO1996009831A3 (de) | Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten | |
NZ333724A (en) | Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions | |
MXPA01005509A (es) | Alimento para bebes estimulantes del crecimiento del timo. | |
GR3034309T3 (en) | IFN--g(b) LIQUID FORMULATIONS | |
DE69313444D1 (de) | IL-6 ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN stabilisiert mit einem nicht-reduzierenden Zucker | |
JO1992B1 (en) | Fixed pharmaceutical compounds based on the derivatives of quinpristine and dalphopristine materials and their preparation process | |
GB8926725D0 (en) | Improvements in or relating to chairs | |
AU3004192A (en) | Stabilized pharmaceutical composition of non-glycosylated recombinant human IL2 in reduced form and its preparation process | |
DE69804674D1 (de) | Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv | |
CA2247998A1 (en) | Fragments of cr1 and their use | |
TH18150B (th) | สารสำเร็จรูปของรีคอมบีแนนท์แฟคเตอร์ viii ที่ปราศจากอัลบิวมินชนิดที่ทำให้เสถียรแล้วซี่งมีปริมาณน้ำตาลต่ำ | |
AU3731689A (en) | Improvements in or relating to electro-magnetically operable devices | |
AU590506B3 (en) | Improvements in and relating to bow ties |